COMPOSITIONS AND METHODS FOR RAPID COVID-19 DETECTION

    公开(公告)号:US20220163522A1

    公开(公告)日:2022-05-26

    申请号:US17532969

    申请日:2021-11-22

    Abstract: The present disclosure provides compositions and methods related to COVID-19 detection. In particular, the present disclosure provides plasmonic metal nanoparticles (MNPs) for use in assays to detect and/or quantify neutralizing antibodies to SARS-CoV-2 in a sample. The compositions and methods of the present disclosure provide a portable, inexpensive, rapid, and accurate antibody assay platform that can be used to evaluate protective immune responses in individuals who have recovered from COVID-19 infection, as well as the efficacy, strength, and duration of vaccines that are under development or in clinical trials.

    METHODS, DEVICES, AND RELATED ASPECTS FOR DETECTING CANNABINOIDS

    公开(公告)号:US20240377418A1

    公开(公告)日:2024-11-14

    申请号:US18659490

    申请日:2024-05-09

    Abstract: Provided herein are methods of detecting cannabinoid molecules in a sample. The methods include contacting the sample with a plurality of plasmonic metal nanoparticles (MNPs) that are conjugated with at least two sets of antibodies, or antigen binding portions thereof, that binds to at least first and second epitopes of the cannabinoid molecule under conditions sufficient for the antibodies, or the antigen binding portions thereof, to bind to the first and second epitopes of the cannabinoid molecule in the sample to produce bound cannabinoid molecules. The methods also include detecting the cannabinoid molecules when aggregations of MNPs coated with the target cannabinoid molecules form by connecting with one another. Related compositions, reaction mixtures, devices, kits, and systems are also provided.

Patent Agency Ranking